STRS Ohio’s Vir Biotechnology VIR Stock Holding History

STRS Ohio’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$293K	Buy	+26,200	New	+$262K	﹤0.01%	1460
2024 Q1	–	Sell	-26,500	Closed	-$266K	–	2038
2023 Q4	$266K	Sell	26,500 -19,500	-42%	-$178K	﹤0.01%	1484
2023 Q3	$431K	Buy	46,000 +9,100	+25%	+$130K	﹤0.01%	1330
2023 Q2	$905K	Buy	36,900 +1,600	+5%	+$40.2K	﹤0.01%	965
2023 Q1	$821K	Buy	35,300 +1,000	+3%	+$25.6K	﹤0.01%	1027
2022 Q4	$868K	Sell	34,300 -9,300	-21%	-$228K	﹤0.01%	999
2022 Q3	$840K	Buy	43,600 +13,300	+44%	+$338K	﹤0.01%	998
2022 Q2	$771K	Buy	30,300 +4,400	+17%	+$103K	﹤0.01%	1071
2022 Q1	$666K	Buy	25,900 +5,200	+25%	+$154K	﹤0.01%	1310
2021 Q4	$866K	Buy	20,700 +1,200	+6%	+$47K	﹤0.01%	1202
2021 Q3	$848K	Buy	19,500 +7,700	+65%	+$333K	﹤0.01%	1214
2021 Q2	$557K	Hold	11,800	–	–	﹤0.01%	1525
2021 Q1	$604K	Hold	11,800	–	–	﹤0.01%	1496
2020 Q4	$316K	Sell	11,800 -4,700	-28%	-$153K	﹤0.01%	1641
2020 Q3	$566K	Buy	16,500 +11,600	+237%	+$499K	﹤0.01%	1253
2020 Q2	$200K	Buy	4,900 +3,000	+158%	+$101K	﹤0.01%	1644
2020 Q1	$65K	Hold	1,900	–	–	﹤0.01%	1749
2019 Q4	$23K	Buy	+1,900	New	+$25.5K	﹤0.01%	1963

Other funds holding VIR

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

STRS Ohio's VIR Position: Q3 2026 in Review

STRS Ohio opened a new position in Vir Biotechnology (VIR) in Q3 2026: 26,200 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #1460 among its holdings. This is a return to the name: STRS Ohio previously reported a position in VIR as recently as Q4 2023.

STRS Ohio first reported a position in VIR in Q4 2019 and has held it in 18 quarters since. The position peaked at $905K in Q2 2023. 111 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

STRS Ohio held 26,200 shares of Vir Biotechnology worth $293K as of Q3 2026.
Vir Biotechnology was a new STRS Ohio position in Q3 2026.
Vir Biotechnology made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1460 holding.
STRS Ohio first reported a position in Vir Biotechnology in Q4 2019 and has held it in 18 quarters since.
STRS Ohio's Vir Biotechnology position peaked at $905K in Q2 2023.
111 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.